Table 1 Main baseline characteristics of the derivation and validation cohort.
Derivation cohort (n = 1276) | Validation cohort (n = 226) | |
|---|---|---|
Age, years | 64 (51;75) | 61 (53;72) |
Males, n (%) | 828 (65) | 156 (69) |
Height, cm | 174 (168;179) | 176 (167;183) |
Weight, kg | 81 (73;91) | 80 (71;90) |
Body surface area, m2 | 1.98 (1.85;2.14) | 2.01 (1.84;2.15) |
Body mass index, kg/m2 | 26.9 (24.6;29.7) | 25.9 (23.8;29.5) |
Indication for ECHO and CMR | ||
Coronary artery disease (existing or suspected), n (%) | 755 (59) | 0 (0) |
Myocarditis (acute or suspected), n (%) | 244 (19) | 59 (26) |
Hypertrophic cardiomyopathy (existing or suspected), n (%) | 131 (10) | 80 (36) |
Non-ischemic dilated cardiomyopathy, n (%) | 83 (7) | 86 (35) |
Other, n (%) | 70 (5) | 1 (0) |
Left ventricular ejection fraction, % units | 56 (43;63) | 46 (25;52) |